Resources (4)

May 14, 2025

FRONTEO and Chugai Pharmaceutical launch co-creation project for target discovery utilizing Drug Discovery AI Factory

Accelerating R&D to Achieve First-in-Class and Best-in-Class Products Through Proprietary Technology That Systematically Discovers Unknown Disease–Molecule Correlations from Known Literature information.

May 12, 2025

FRONTEO and Institute of Science Tokyo Launch Joint Research on New Drug Discovery Targets Using the Drug Discovery AI Factory

Verifying AI-Detected Drug Targets Through Both Dry and Wet Research to Develop Medicines Addressing Unmet Medical Needs

May 11, 2025

EA Pharma and FRONTEO Launch Co-Creation Project for AI-Powered Target Discovery in Drug Development

May 7, 2025

Making the Pharmaceutical Industry a Core Industry in Japan: Launch of the “FRONTEO Co-creation Drug Discovery Ecosystem”

Centered on the AI-driven drug discovery support service “Drug Discovery AI Factory,” the company aims to solve drug discovery challenges and create innovative pharmaceuticals through collaboration with diverse co-creation partners

Jan 27, 2025

FRONTEO and Eisai launch co-creation project for target discovery using Drug Discovery AI Factory

Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.

Jan 15, 2025

Publication of White Paper on innovative drug discovery approach using Springer Nature’s literature data and FRONTEO’s specialized AI engine KIBIT

FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.

Jan 8, 2025

FRONTEO and Maruishi Pharmaceutical launch co-creation project for biomarker discovery using Drug Discovery AI Factory

Accelerate pharmaceutical research and development with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature.

Dec 16, 2024

Skadden Arps Slate Meagher & Flom LLP and Affiliates Webinar Report

Nov 13, 2024

UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory

Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.

Nov 11, 2024

FRONTEO and Daiichi Sankyo signed an agreement for optimization and analysis of toxicity information with Drug Discovery AI Factory

Supporting the construction of innovative AI discovery systems to derive new findings from toxicity study database and toxicity study reports

Oct 27, 2024

Covington & Burling LLP Webinar Report

Sep 29, 2024

Winston & Strawn LLP Webinar Report

2 3 4 5 6

Resources